Commonly Prescribed Medications Recalled Due to Cancer Concerns
The U.S. Food and Drug Administration has issued another recall concerning a commonly prescribed medication after laboratory tests indicated 33 batches contained Nitrosodimethylamine (NDMA), a known carcinogen. The recalled metformin tablets were distributed throughout the United States and the United Kingdom. The Food and Drug … [Read more...]
The Number of Metformin Products Recalled Exploded in 2020
Metformin Lawsuits Seeking Monetary Compensation Due to Cancerous N-nitrosodimethylamine (NDMA) Contamination is Likely to Explode in 2021 and Beyond. THE UNITED STATES - According to a news report posted on  medpagetoday.com, the total number of Metformin products recalled in 2020 grew substantially. The most recent list of … [Read more...]
Granules Pharmaceuticals Metformin Hydrochloride NDMA Lawsuits
Granules Pharmaceuticals, Inc. Recalls its 750 mg Extended-Release Tablet of USP Metformin Hydrochloride (Metformin) Due to NDMA Carcinogen Contamination WASHINGTON, D.C. — The U.S. Food and Drug Administration, FDA, announced that the prescription drug maker Granules Pharmaceuticals, Inc. issued a voluntary recall for its 750 … [Read more...]
Nizatidine Oral Solution Recalled
WASHINGTON, D.C. — Amneal Pharmaceuticals, LLC, announced that it must recall from consumer stores, wholesalers, distributors, and customers, the heartburn medication known as Nizatidine. According to Nasdaq.com, Amneal Pharmaceuticals recall program is due to a potential nitrosamine impurity in its medication called … [Read more...]
Another Ranitidine Product Recalled
BRIDGEWATER, New Jersey — Amneal Pharmaceuticals, LLC, from Bridgewater, New Jersey announced that the company would recall several lots of its Ranitidine products because of N-Nitrosodimethylamine (NDMA) impurities found in its products. Scientists have identified NDMA as a potential carcinogen. NDMA exists in much of the food … [Read more...]
